SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ambalal Sarabhai Ent reports Profit after tax of Rs 16.18 Mln, in the December 2022 quarter

10 Feb 2023 Evaluate
The revenue for the December 2022 quarter is pegged at Rs. 12.16 millions against Rs. 0.00 millions recorded during the year-ago period.The Total Profit for the quarter ended December 2022 of Rs. 16.18 millions grew from Rs.-1.74 millions Operating profit Margin for the quarter ended December 2022 improved to 16.71% as compared to -0.96% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 12.16 0.00 0.00 33.37 0.00 0.00 1.27 0.00 0.00
Other Income 27.89 11.83 135.76 71.89 327.66 -78.06 395.35 296.13 33.51
PBIDT 16.71 -0.96 -1840.63 33.28 287.16 -88.41 339.68 -85.32 -498.12
Interest 0.17 0.27 -37.04 0.58 1.20 -51.67 2.47 5.58 -55.73
PBDT 16.54 -1.23 -1444.72 32.27 134.83 -76.07 36.44 -90.90 -140.09
Depreciation 0.34 0.48 -29.17 1.19 1.43 -16.78 1.92 3.78 -49.21
PBT 16.20 -1.71 -1047.37 31.08 133.40 -76.70 34.52 -94.68 -136.46
TAX 0.02 0.03 -33.33 1.13 -0.36 -413.89 4.96 -0.81 -712.35
Deferred Tax 0.02 0.03 -33.33 1.13 -0.36 -413.89 7.46 -2.91 -356.36
PAT 16.18 -1.74 -1029.89 29.95 133.76 -77.61 29.56 -93.87 -131.49
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) 137.42 0.00 0.00 99.73 0.00 0.00 26746.46 0.00 0.00

Ambalal Sarabhai Ent Share Price

31.07 -0.26 (-0.83%)
06-May-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 940.00
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×